{"schema_version":"secwatch.filing_event.v1","accession":"0000950103-24-006462","form_type":"8-K","ticker":"ADCT","cik":"0001771910","company_name":"ADC Therapeutics SA","filed_at":"2024-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.997826+00:00","generated_at":"2026-06-02T12:08:51.571255+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ADC Therapeutics raises ~$105M in public offering of common shares and pre-funded warrants","bullets":["Offered 13.4M common shares at $4.90/share and pre-funded warrants for 8.2M shares at $4.812/warrant.","Gross proceeds ~$105M; underwriters include Jefferies, Guggenheim, Cantor Fitzgerald; offering closed May 8, 2024.","Pre-funded warrants exercisable at CHF 0.08/share, with a 9.99% beneficial ownership cap (adjustable to 19.99%).","Warrants have a 10-year term and may be exercised on a cashless basis under certain conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-24-006462","json":"https://secwatch.observer/filing/0000950103-24-006462.json","markdown":"https://secwatch.observer/filing/0000950103-24-006462.md","text":"https://secwatch.observer/filing/0000950103-24-006462.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1771910/000095010324006462/0000950103-24-006462-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1771910/000095010324006462/dp210968_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T12:08:51.571255+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}